NOVONIX Announces Completion of Due Diligence for Combination of Natural Graphite Interests into Axon Graphite
2024年5月16日 - 9:59AM
NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX”), a leading
battery materials and technology company, today announced that due
diligence has been satisfactorily completed for both NOVONIX and
Lithium Energy Limited (ASX: LEL)(“LEL”) to contribute their
natural graphite exploration interests into a new company, Axon
Graphite Limited (“Axon”).
As previously announced, NOVONIX has agreed to divest MD South
Tenements Pty Ltd, its wholly owned subsidiary that holds the Mount
Dromedary natural graphite exploration interests, to Axon Graphite
Limited, a subsidiary of LEL. LEL will contribute its interest in
its Burke and Corella graphite projects to Axon pursuant to the
agreement. As consideration for the transaction, NOVONIX will
receive shares in Axon, which the parties intend to list on the
Australian Securities Exchange (“ASX”). The transaction is subject
to the completion of the proposed initial public offering (“IPO”)
of Axon, and receipt of approval for the admission of Axon to the
ASX.
This announcement has been authorized for release by NOVONIX
Chairman, Admiral Robert J. Natter, USN Ret.
About NOVONIX NOVONIX is a leading battery
technology company revolutionizing the global lithium-ion battery
industry with innovative, sustainable technologies,
high-performance materials, and more efficient production methods.
The company manufactures industry-leading battery cell testing
equipment, is growing its high-performance synthetic graphite anode
material manufacturing operations, and has developed an all-dry,
zero-waste cathode synthesis process. Through advanced R&D
capabilities, proprietary technology, strategic partnerships, and
as a leading North American supplier of battery-grade synthetic
graphite, NOVONIX has gained a prominent position in the electric
vehicle and energy storage systems battery industry and is powering
a cleaner energy future. To learn more, visit us at
www.novonixgroup.com or on LinkedIn and X.
For NOVONIX Limited Scott
Espenshade, ir@novonixgroup.com (investors) Valerie Malone,
media@novonixgroup.com (media)
Cautionary Note Regarding Forward-Looking
Statements
This communication contains forward-looking statements about the
Company and the industry in which we operate. Forward-looking
statements can generally be identified by use of words such as
“anticipate,” “believe,” “contemplate,” “continue,” “could,”
“estimate,” “expect,” “intend,” “may,” “plan,” “potential,”
“predict,” “project,” “should,” “target,” “will,” or “would,” or
other similar expressions. Examples of forward-looking statements
in this communication include statements we make regarding the
proposed transaction with Lithium Energy Limited and the proposed
Axon Graphite Limited IPO and ASX listing, We have based these
forward-looking statements on our current expectations and
projections about future events and trends that we believe may
affect our financial condition, results of operations, business
strategy and financial needs. Such forward-looking statements
involve and are subject to known and unknown risks, uncertainties
and other factors which may cause our actual results, performance
or achievements to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking statements. Factors that could affect our business
and results are included in our filings with the U.S. Securities
and Exchange Commission (“SEC”), including the Company's Form 20-F.
Copies of these filings may be obtained by visiting our Investor
Relations website at www.novonixgroup.com or the SEC's
website at www.sec.gov.
Forward-looking statements are not guarantees of future
performance or outcomes, and actual performance and outcomes may
differ materially from those made in or suggested by the
forward-looking statements contained in this communication.
Accordingly, you should not place undue reliance on forward-looking
statements. Any forward-looking statement in this communication is
based only on information currently available to us and speaks only
as of the date on which it is made. We undertake no obligation to
publicly update any forward-looking statement, whether written or
oral, that may be made from time, whether as a result of new
information, future developments or otherwise, except as required
by law.
In particular, we caution that the proposed Axon IPO and ASX
listing may be subject to final board and regulatory approvals and
is dependent on market conditions. We caution that the admission of
Axon to the official list of the ASX is conditional on and subject
to the ASX’s satisfaction that Axon has a structure and operations
suitable for a listed entity at the ASX’s absolute discretion.
In accordance with section 734(5)(b) of the Corporations
Act 2001 (Cth) (Corporations Act), it is noted that:
- Axon will be the offeror of fully paid ordinary shares under
the IPO;
- a prospectus will be issued by Axon in accordance with Part 6.2
of the Corporations Act when the IPO shares are offered;
- a person should consider the prospectus in deciding whether to
apply for IPO shares; and
- anyone who wants to apply for the IPO will need to complete an
application form that will be in or will accompany the
prospectus.